shows histamine-induced itch duration data for the treated and control sides at each time point. Pair-wise comparisons were performed to assess the itch duration in (1) cryolipolysis treatment vs control side at each time point, and (2) post-treatment data vs baseline (for treated site, as well as control site.
For treated vs control analysis, there were no significant differences in itch duration at any time point. At the treated side, post-treatment itch duration was significantly decreased at 48-72hr, and between Days 14 to 56 when compared to baseline. At the control side, post-treatment itch duration was significantly decreased at all time points when compared to baseline. Table S2 shows histamine-induced itch intensity data for the treated and control sides at each time point. Pair-wise comparisons were performed to assess the itch intensity in (1) cryolipolysis treatment vs control side at each time point, and (2) post-treatment data vs baseline (for treated site, as well as control site). There are no significant differences in mean itch intensity at the treated side or at the control side following histamine-iontophoresis.
There are no differences in itch intensity between control and treated sides at each time point. 
C. Wheal and flare reaction:
Erythema (flare) and wheal diameter at 10 minutes after histamine iontophoresis were measured at each time point. Table S4 shows histamine-induced erythema (flare) diameter was significantly smaller in the treated flank at 48-72 hrs, Days 7-, 21-, and 35-when compared to the control side. At the treated side, histamine-induced erythema diameter was significantly decreased at Days 7, 21 and 35 when compared to baseline. At the control side, histamineinduced erythema diameter was significantly decreased from Day 14 to Day 56 when compared to baseline. There were no significant differences in the wheal size at each time point (data not shown). 
